Pharmacogenomics in clinical therapeutics / (Record no. 19163)

MARC details
000 -LEADER
fixed length control field 03609cam a2200481Ka 4500
001 - CONTROL NUMBER
control field ocn779616174
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20220701010842.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION
fixed length control field m o d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cn|||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 120309s2012 nju ob 001 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency DG1
Language of cataloging eng
Transcribing agency DG1
Modifying agency TXA
-- YDXCP
-- OCLCQ
-- OCLCA
-- GWM
-- OCLCQ
-- OCLCF
-- OCLCQ
-- DG1
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9781119959601
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 1119959608
Qualifying information (electronic bk.)
029 1# - (OCLC)
OCLC library identifier AU@
System control number 000049013993
029 1# - (OCLC)
OCLC library identifier GBVCP
System control number 790036355
029 1# - (OCLC)
OCLC library identifier NZ1
System control number 15900691
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)779616174
037 ## - SOURCE OF ACQUISITION
Stock number 10.1002/9781119959601
Source of stock number/acquisition Wiley InterScience
Note http://www3.interscience.wiley.com
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RM301.3.G45
Item number P4235 2012
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.7
Edition number 22
049 ## - LOCAL HOLDINGS (OCLC)
Holding library MAIN
245 00 - TITLE STATEMENT
Title Pharmacogenomics in clinical therapeutics /
Statement of responsibility, etc edited by Loralie J. Langman and Amitava Dasgupta.
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc Hoboken :
Name of publisher, distributor, etc John Wiley & Sons,
Date of publication, distribution, etc 2012.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (ix, 244 pages)
336 ## -
-- text
-- txt
-- rdacontent
337 ## -
-- computer
-- c
-- rdamedia
338 ## -
-- online resource
-- cr
-- rdacarrier
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Front Matter -- Pharmacogenomics Principles: Introduction to Personalized Medicine / Parvaz Madadi, Gideon Koren -- Traditional Therapeutic Drug Monitoring and Pharmacogenomics: Are They Complementary? / Christine L H Snozek, Loralie J Langman, Amitava Dasgupta -- Pharmacogenomics Aspect of Warfarin Therapy / Matthew D Krasowski -- Pharmacogenetics and Cancer Chemotherapy / Christine L H Snozek -- Pharmacogenomic Considerations in Anesthesia and Pain Management / Christine M Formea, Wayne T Nicholson -- Pharmacogenomics of Immunosuppressants / Nicolas Picard, Pierre Marquet -- Pharmacogenomics of Cardiovascular Drugs / Linnea M Baudhuin -- Pharmacogenomic Aspects of Antiretroviral Therapy / Natella Y Rakhmanina, John N van den Anker -- Pharmacogenetics of Psychoactive Drugs / Jorge L Sepulveda -- Pharmacogenomic Aspects of Adverse Drug-Drug Interactions / Loralie J Langman, Christine L H Snozek -- Microarray Technology and Other Methods in Pharmacogenomics Testing / Jorge L Sepulveda -- Pharmacogenetic Testing in the Clinical Laboratory Environment / Mark P Borgman, Mark W Linder -- Index.
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
520 ## - SUMMARY, ETC.
Summary, etc Pharmacogenomics is the process of analyzing patients' genes to predict the onset of adverse reactions or forecast the effectiveness of therapeutic drugs. This useful text is written to discuss both the theory and the clinical application of the principles of pharmacogenomics. Current research has clearly established that a range of treatments may be greatly improved through genetic profiling of individual patients before certain therapies begin. Aimed at clinicians, pharmacologists, and clinical laboratory professionals this book discusses the important role of laboratory tests in the practice of personalized medicine. An important new book, Pharmacogenomics in Clinical Therapeutics serves as a guide to the basic principles of pharmacogenomics in a range of common therapeutic areas and as the basis of the personalized medicine of the future.
588 0# -
-- Print version record.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmacogenetics.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Chemotherapy.
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Chemotherapy.
Source of heading or term fast
-- (OCoLC)fst00853595
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Pharmacogenetics.
Source of heading or term fast
-- (OCoLC)fst01060243
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Langman, Loralie J.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Dasgupta, Amitava,
Dates associated with a name 1958-
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element Wiley InterScience (Online service)
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://dx.doi.org/10.1002/9781119959601">http://dx.doi.org/10.1002/9781119959601</a>
Public note Wiley Online Library
994 ## -
-- 92
-- DG1

No items available.